King posts net loss and flat revenues
This article was originally published in Scrip
Executive Summary
King Pharmaceuticals posted a net loss of $11 million in the first quarter of 2009 following restructuring and inventory charges associated with the acquisition of Alpharma. This compares with a net profit of $86 million in the same quarter of 2008.